The largest cranial nerve is the trigeminal nerve which got its name -"trigeminal" -is derived from the fact that each nerve, one on each side of the pons, has three major branches: the ophthalmic nerve (V1), the maxillary nerve (V2) and the mandibular nerve (V3). Purely sensory are the ophthalmic and maxillary nerves, the mandibular nerve has both sensory and motor functions
Case Report:
The patient Mrs. Masuma Begum 58 years of age admitted in CMH Dhaka with the complaints of pain in right side of the face for 7 years She mentioned that pain aggravates while eating, swallowing, washing her face, clenching her teeth and even on touching. She doesn't experience pain while sleeping. Patient described the pain as severe, unbearable, intermittent, shock like and unilateral. She visited a private dentist in Dhaka and also consulted to neurophysician .The patient was treated by conservative treatment for last 7 years.For last 7 months she is refractory to conservative treatment. There are some etiological factors are considered to cause the problem..The etiological factors may be grouped into three major theories . 1) Disease related 2) Direct injury to the nerve and 3) Poly etiologic origin although compression of the trigeminal nerve root is considered the most common cause of neuralgia nerve (Table 3) . The treatment modalities of TN can be divided into pharmacological and surgical intervention. In general, patients show a good response to drug therapy with over 80% using anticonvulsants. Carbamazepine (Tegretol, Summit) is generally used as the first drug of choice in the management of TN. Its mechanism of action is neuronal excitability depression, blocks Na + channels, thereby leading to a selective reduction in the ectopic neural discharges that are responsible for the pain. This drug is used for therapeutic diagnosis of TN. Usually, we start with low dose and gradually increase the dosage. Maximum dosage of carbamazepine that can be given is 1200-2400 mg. Periodic follow-up and blood tests should be conducted to rule out neutropenia as it is an adverse effect of long-term use of carbamazepine. Secondline therapeutics includes drugs such as phenytoin and baclofen, which has carbamazepine-like mechanism of action. Other drugs such as pimozide, sodium valproate, and clonazepam are also used. Clonazepam 0.5 mg t.i.d is preferred dosage. However, the drawback is that these drugs have shown unclear efficacy. These drugs are associated with major side effects such as nausea, weakness, gingival enlargement, ataxia, and erythematous skin rashes. For approximately 30% of patients with TN, pharmacological intervention fails due to unsuccessful pain control or because of the adverse reactions of the drugs, and 50% eventually become unresponsive due to the tolerability of medication. For these patients, surgical procedures are carried out .Cryotherapy, alcohol or anesthetic injection, or neurectomy will help in attaining peripheral block of trigeminal branches. Cryotherapy when performed leads to necrosis of the affected nerve branch. This method initially gives good results but has higher recurrence rate.The surgical management of trigeminal neuralgia is resorted as a treatment only when the medical management does not provide relief for the patient and pain continuous to manifest its severity. Just as our patient experienced severe pain even after a trial of various drugs. 
Conclusion:
it is important to recognize that very small tumors would cause TN. Since such tumors can be overlooked on routine MR studies, high-resolution thin-sliced MR examinations and careful radiological interpretations are required for correct diagnosis and treatment. But most important thing is, if no definite pathology is identified and patient having pain refractory to medical treatment: micro vascular decompression is the final remedy.
